Thor Industries
THO
$70.10
-0.86%
Thor Industries is the world's largest manufacturer of recreational vehicles, producing travel trailers, fifth-wheels, Class A/B/C motorhomes, and European motor caravans and caravans across roughly 35 brands, with a smaller aftermarket parts business (Airxcel) representing under 10% of fiscal 2025 sales. Its scale, brand portfolio breadth, and dual North American/European footprint (via the 2019 Erwin Hymer acquisition) make it the closest thing to a category leader in a highly fragmented, dealer-dependent industry. The current investor debate centers on a sharp profitability squeeze: recent quarterly results showed revenue beating estimates while EPS missed significantly, and management's cautious full-year outlook citing geopolitical uncertainty has weighed heavily on sentiment. With the stock down more than a third over the past year and trading near the bottom of its 52-week range, the narrative has shifted from cyclical recovery to questions about whether margin compression is transitory or structural.…
THO
Thor Industries
$70.10
Related headlines
Investment Opinion: Should I buy THO Today?
Rating: Hold. Thor is a deeply discounted cyclical (P/B 0.92x, P/S 0.41x, forward PE 14.14x) whose earnings power is unproven, and the analyst consensus of 'hold' with a mean rating of 2.53 and an average target of $84.30 (+23.2%) captures that tension — the upside exists but is a function of how far the stock has fallen rather than fresh conviction. Supporting evidence is mixed but leans toward patience: revenue is holding at $9.6B with consensus forward revenue of $10.72B (modest growth), the balance sheet is conservative (debt-to-equity 0.204, current ratio 1.77), and price-to-cash-flow of 12.22 shows the business still generates cash. But profitability is the problem — net margin 1.85%, operating margin 2.05%, ROE 4.17%, ROA 1.76% — and the recent revenue beat/EPS miss pattern shows growth is low-quality. The forward PE of 14.14x only looks fair if the $5.29 forward EPS estimate holds; the trailing-to-forward gap of 156x makes that estimate the entire thesis. The biggest risks are a further leg down in margins, downward EPS revisions, and a dividend cut given the 61.3% payout ratio. This Hold would upgrade to Buy if gross margin stabilizes above 13% for two consecutive quarters and forward EPS estimates hold near $5.29, or downgrade to Sell if the stock breaks decisively below the $62.83 52-week low or if forward EPS estimates are cut below $4.50. Valuation verdict: fairly valued to modestly undervalued on normalized earnings, but genuinely cheap only if the recovery materializes — the market is pricing a recovery that has not yet appeared in margins.
Sign up to view all
THO 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Thor Industries's 12-month outlook, with a consensus price target around $83.20 and implied upside of +18.7% versus the current price.
Average Target
$83.20
0 analysts
Implied Upside
+18.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$53 - $126
Analyst target range
Ten analysts cover Thor with a consensus recommendation of "hold" (mean rating 2.53 on a 1-to-5 scale where lower is more bullish), reflecting a distinctly neutral-to-cautious stance. The average target price of $84.30 implies roughly +23.2% upside from the current $68.44, which sounds constructive but is largely a function of how far the stock has fallen rather than fresh enthusiasm. Consensus forward EPS of $5.29 and revenue of $10.72 billion suggest analysts expect a meaningful earnings recovery even as they refrain from recommending the stock — a tension that signals low conviction in the timing of any turnaround.
The target range is extremely wide, from $53.00 to $126.00 — a 138% spread that signals high uncertainty and weak conviction across the coverage universe. The high target of $126.00 implies a full cyclical recovery with margin normalization and multiple expansion back toward prior-cycle levels, while the low target of $53.00 prices in continued margin compression, dealer destocking, and estimate cuts. With the stock at $68.44, the average target sits above the current price but the low end is 22.5% below it, meaning the downside scenario is as live as the upside. Given the recent EPS miss and cautious guidance, the risk skews toward downgrades and target cuts rather than upgrades, and the 6.4-day short ratio suggests bears remain firmly positioned.
Bulls vs Bears: THO Investment Factors
The bear case currently has stronger evidence: margins at 1.85% net and 2.05% operating are near breakeven, the most recent quarter delivered a revenue beat but a significant EPS miss, and the stock is pinned near its 52-week low with -50% relative strength versus the S&P. The bull case rests almost entirely on valuation — P/B of 0.92x, P/S of 0.41x, forward PE of 14.14x — and on a forward EPS estimate of $5.29 that has not yet been validated by actual results. The single most important tension is whether the margin compression is transitory (input costs, dealer destocking, promotional pricing that normalizes) or structural (a permanently lower-margin RV market). If margins recover toward historical levels, the stock is deeply undervalued; if they don't, the forward EPS estimate gets cut and the apparent discount evaporates. Analyst consensus of 'hold' with a 138% target spread ($53–$126) reflects exactly this unresolved debate.
Bullish
- Deep value on book and sales: THO trades at P/B of 0.92x and P/S of just 0.41x, meaning the market values the world's largest RV maker below its accounting book value. For a company with $9.6B in fiscal 2025 revenue and 181,388 wholesale units, this is the kind of discount historically seen only at cyclical troughs.
- Conservative balance sheet provides survival buffer: Debt-to-equity of 0.204 and a current ratio of 1.77 mean Thor can absorb a prolonged downturn without external financing. Price-to-cash-flow of 12.22 confirms the business still generates meaningful operating cash flow despite the earnings compression.
- Analyst average target implies 23% upside: The consensus average target of $84.30 implies +23.2% upside from $68.44, and the high target of $126.00 implies +84%. Even the low target of $53.00 is only 22.5% below current levels, giving a moderately asymmetric risk/reward skew on the sell-side view.
- Forward PE of 14x is reasonable on normalized earnings: Forward PE of 14.14x against a forward EPS estimate of $5.29 is roughly in line with typical mid-teens multiples for cyclical industrials. EV/EBITDA of 7.96x is modest in absolute terms for a market leader at a trough.
Bearish
- Margins are dangerously thin: Net margin of 1.85%, operating margin of 2.05%, and gross margin of 12.62% leave almost no cushion for input cost inflation or promotional discounting. A modest demand shock could push the company toward breakeven, making low leverage a necessary buffer rather than upside optionality.
- Earnings quality is deteriorating: The most recent quarter saw revenue beat estimates while EPS missed significantly, and Q2 commentary cited margins squeezing despite strong sales. Volume is being purchased with price and mix concessions — top-line resilience is not translating into earnings power.
- Trailing-to-forward EPS gap looks stale: Trailing EPS of $0.045 versus a forward estimate of $5.29 implies a 156x earnings rebound. That gap is either an enormous recovery opportunity or a sign that estimates are vulnerable to downward revision, and the recent EPS miss skews the risk toward cuts.
- Technical downtrend with no floor yet: THO is down 34.49% over one year and 35.08% YTD, sitting at roughly 9.4% of its 52-week range ($62.83–$122.83). Relative strength versus the S&P 500 is -50.02% over one year, confirming capital flight rather than a market-wide drag.
THO Technical Analysis
Thor is in a sustained, broad-based downtrend. The stock is down 34.49% over the past year and 35.08% year-to-date, and at $68.44 it sits at roughly 9.4% of its 52-week range of $62.83 to $122.83 — essentially pinned near the lows, which historically signals either capitulation/value territory or a falling knife absent a catalyst. The maximum drawdown of -46.93% confirms the severity of the de-rating, and relative strength versus the S&P 500 is deeply negative at -50.02% over one year, meaning this is a clear case of capital fleeing the name rather than a market-wide drag.
Short-term momentum offers no relief and is actually deteriorating. The 1-month change of -1.86% and 3-month change of -10.27% show the decline accelerating rather than decelerating, with the 3-month figure materially worse than the 6-month change of -15.03% would imply on a run-rate basis. The most recent price action is telling: a bounce to $69.98 on October 15 was immediately rejected, closing at $68.44 on October 16 (-2.20% on the day), and the stock has made a sequence of lower highs from the September $73.80 level down to the October $63.87 low. Relative strength is negative across every window (-3.08% 1-month, -12.96% 3-month, -22.51% 6-month), confirming persistent underperformance versus the SPY's +15.53% one-year gain.
Key technical levels are well defined. Support sits at the 52-week low of $62.83, with the October 9 close of $63.87 marking the recent test; a decisive breakdown below $62.83 would signal a fresh leg lower and likely trigger momentum-driven selling. Resistance is layered: the $73.80 September swing high, then the 52-week high of $122.83 far above. A beta of 1.417 means the stock is roughly 42% more volatile than the market, so position sizing should account for amplified drawdowns — a short ratio of 6.4 days-to-cover also indicates meaningful bearish positioning that could fuel sharp squeezes on any positive catalyst.
Beta
1.42
1.42x market volatility
Max Drawdown
-46.9%
Largest decline past year
52-Week Range
$63-$123
Price range past year
Annual Return
-35.7%
Cumulative gain past year
| Period | THO Return | S&P 500 |
|---|---|---|
| 1m | -3.1% | -1.0% |
| 3m | -8.6% | +2.9% |
| 6m | -11.3% | +6.5% |
| 1y | -35.7% | +13.1% |
| ytd | -33.5% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
THO Fundamental Analysis
Revenue is holding up better than earnings, but the trajectory is decelerating. Fiscal 2025 revenue was $9.6 billion on 181,388 wholesale units, and consensus estimates point to roughly $10.72 billion for the forward period (range $10.33B–$11.11B), implying modest top-line growth. However, the most recent quarter saw revenue beat estimates while EPS missed significantly, a pattern that suggests volume is being purchased with price and mix concessions. The Q2 commentary about margins squeezing despite strong sales reinforces that the growth being delivered is low-quality — top-line resilience is not translating into earnings power, which undermines the investment case for a cyclical recovery.
Profitability is thin and under pressure. Net margin is just 1.85%, operating margin 2.05%, and gross margin 12.62% — levels that leave almost no cushion for input cost inflation, promotional discounting, or fixed-cost deleverage. ROE of 4.17% and ROA of 1.76% are well below what a market leader in a cyclical industry should earn at mid-cycle, and trailing EPS of $0.045 versus a forward estimate of $5.29 implies the market expects a dramatic earnings rebound — a gap that is either an enormous recovery opportunity or a sign that estimates are stale and vulnerable to downward revision. The payout ratio of 61.3% against such depressed earnings raises a dividend sustainability question even with the 2.77% yield.
Balance sheet strength is the one clear bright spot. Debt-to-equity of 0.204 and a current ratio of 1.77 indicate a conservatively levered, liquid balance sheet that can weather a downturn without external financing. Price-to-cash-flow of 12.22 suggests the business still generates meaningful operating cash flow despite the earnings compression, and EV/EBITDA of 7.96 is modest in absolute terms. The risk is not solvency but earnings quality: with net margin at 1.85% and operating margin at 2.05%, a modest demand shock could push the company toward breakeven, making the low leverage a necessary buffer rather than a source of upside optionality.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is THO Overvalued?
Because trailing net income is positive (albeit barely, with EPS of $0.045), the PE ratio is the primary metric, but it is nearly meaningless at 22.1x trailing given the depressed denominator. The more informative comparison is forward PE of 14.14x against the forward EPS estimate of $5.29 — a 156x gap between trailing and forward earnings that tells you the market is pricing a full cyclical earnings recovery, not current profitability. On EV/Sales of 0.42x and P/S of 0.41x, the stock looks cheap in absolute terms, but that is typical for a low-margin, cyclical manufacturer and must be weighed against the 12.62% gross margin.
Peer comparison is constrained by the absence of industry-average multiples in the provided data, but the internal spread is instructive: P/B of 0.92x means the market values Thor below book, a discount that typically signals either deep cyclical pessimism or expected returns below cost of capital. EV/EBITDA of 7.96x is reasonable for an RV manufacturer at a cyclical trough, and the 2.77% dividend yield with a 61.3% payout ratio offers some valuation support. The PEG ratio of -0.73 is not analytically useful given the negative growth denominator, so the forward PE of 14.14x versus the sector's typical mid-teens multiple suggests the stock is roughly fairly valued on normalized earnings — neither a screaming bargain nor expensive.
Historical ratio data was not provided, so a precise band comparison is not possible. Qualitatively, however, a P/B below 1.0x and a forward PE near 14x are consistent with the low end of Thor's historical valuation range during prior cyclical troughs, which supports the value case but also reflects genuine fundamental deterioration rather than a temporary dislocation. The market is pricing in a recovery that has not yet appeared in margins, so the risk/reward hinges on whether the forward EPS estimate of $5.29 proves achievable — if it does, the stock is cheap; if estimates get cut, the apparent discount evaporates.
PE
22.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on earnings fragility. Net margin of 1.85% and operating margin of 2.05% mean a modest demand shock or input cost spike could push Thor toward breakeven, and the recent quarter's revenue beat paired with a significant EPS miss shows the company is buying volume with price and mix concessions. The 61.3% payout ratio against trailing EPS of $0.045 puts the 2.77% dividend at risk if earnings don't recover. Revenue concentration in cyclical discretionary RVs, with the aftermarket Airxcel business under 10% of fiscal 2025 sales, leaves little recurring revenue to cushion a downturn. The balance sheet (debt-to-equity 0.204, current ratio 1.77) is a genuine strength, but it is a survival buffer rather than a source of upside. Market and competitive risks are dominated by valuation compression and cyclicality. Beta of 1.417 means THO is roughly 42% more volatile than the market, so any macro risk-off move is amplified; the stock's -50.02% one-year relative strength versus the S&P's +15.53% shows how violently capital has fled. The dealer-dependent, highly fragmented RV industry means promotional discounting by competitors can compress Thor's already-thin gross margin of 12.62%. Management's own cautious full-year outlook citing geopolitical uncertainty, plus the Q2 headline that 'geopolitical events clouded our outlook,' signals limited visibility. The 6.4-day short ratio also means bearish positioning is entrenched and could pressure the stock on any negative print. The worst-case scenario is a chain of events where dealer destocking persists, promotional pricing keeps gross margin near 12.6%, and forward EPS estimates of $5.29 get cut toward the low estimate of $4.41 or below. That would push the stock toward the analyst low target of $53.00, roughly -22.5% from $68.44, and a decisive break below the 52-week low of $62.83 would likely trigger momentum-driven selling toward that level. In a deeper recession scenario with a dividend cut, the drawdown could approach the historical max drawdown of -46.93%, implying a price near $36 — an investor could realistically lose 20–35% from current levels in an adverse scenario.
FAQ
The most severe risk is margin fragility: net margin of 1.85% and operating margin of 2.05% mean a modest demand shock could push Thor toward breakeven, and the recent quarter's revenue beat with a significant EPS miss shows volume is being bought with price concessions. Second is estimate risk — the 156x gap between trailing EPS of $0.045 and forward EPS of $5.29 makes the stock highly vulnerable to downward revisions, which would push it toward the analyst low target of $53.00. Third is technical and macro risk: the stock is down 34.49% over one year with -50.02% relative strength versus the S&P, and a beta of 1.417 amplifies any risk-off move, with a break below $62.83 likely triggering momentum selling. Fourth is dividend risk, with a 61.3% payout ratio against depressed earnings raising the possibility of a cut to the 2.77% yield.
The 12-month forecast has three scenarios: a base case (55% probability) of $75–$90, assuming forward EPS near $5.29 is roughly achieved and margins stabilize near 12.6%, keeping the stock around the analyst average target of $84.30; a bear case (25% probability) of $53–$63, assuming EPS estimates are cut toward $4.41 and the stock breaks the $62.83 52-week low toward the analyst low target of $53.00; and a bull case (20% probability) of $110–$126, assuming gross margin recovers above 13.5% and the multiple re-rates toward the high target of $126.00. The base case is most likely, and its key assumption is that the forward EPS estimate of $5.29 proves achievable rather than stale.
THO looks undervalued on asset and sales metrics but only fairly valued on normalized earnings. P/B of 0.92x means the market values Thor below book, and P/S of 0.41x and EV/Sales of 0.42x are deep cyclical-trough levels for a $9.6B-revenue market leader. However, the trailing PE of 22.1x is meaningless given EPS of $0.045, and the forward PE of 14.14x is roughly in line with typical mid-teens industrial multiples — fair, not cheap, if the $5.29 forward EPS holds. The market is pricing a full cyclical earnings recovery that has not yet appeared in margins, so the apparent discount is conditional: if estimates get cut, the valuation support evaporates.
From a risk/reward perspective, THO is a speculative value play rather than a clean buy. The stock at $68.44 offers +23.2% upside to the analyst average target of $84.30 and +84% to the high target of $126.00, but the low target of $53.00 implies -22.5% downside, and the recent revenue beat/EPS miss pattern shows earnings quality is deteriorating. Valuation is genuinely cheap at P/B 0.92x and P/S 0.41x with a conservative balance sheet (debt-to-equity 0.204), but the forward PE of 14.14x depends entirely on a $5.29 EPS estimate that has not been validated. It is a good buy only for patient, risk-tolerant investors who can withstand a 1.417 beta and a possible 20–35% drawdown, and ideally only after gross margin shows signs of stabilizing above 13%.
THO is better suited to long-term value investors than short-term traders, but only for those with high risk tolerance. The stock is in a sustained downtrend (-34.49% over one year, -35.08% YTD) with a beta of 1.417 and a max drawdown of -46.93%, making short-term trading hazardous absent a clear catalyst. The 2.77% dividend yield offers some carry, but the 61.3% payout ratio makes it unreliable income. Earnings visibility is low given the cautious full-year outlook and geopolitical uncertainty, so the recovery thesis needs time to play out. A suggested minimum holding period is 2–3 years, allowing for a full RV cycle and margin normalization, with position sizing that accounts for the amplified volatility.